Lubrano, Ennio
Delle Sedie, Andrea
Romanelli, Marco
Chimenti, Maria Sole
Bianchi, Luca
Piaserico, Stefano
De Felice, Catia
Graceffa, Dario
De Andres, Maria Ilenia
Curatolo, Salvatore
Grembiale, Rosa Daniela
Dastoli, Stefano
Arcuri, Chiara
Angileri, Rosa Giuseppa
Prignano, Francesca
Bandinelli, Francesca
Baldissera, Elena
Mercuri, Santo Raffaele
Franchi, Chiara
Longhi, Matteo
Patrì, Angela
Caso, Francesco
Passiu, Giuseppe
Montesu, Maria Antonia
Parisi, Simone
Stroppiana, Elena
di Luzio, Genoveffa Scotto
Italiano, Giovanni
Di Nuzzo, Sergio
Santilli, Daniele
Bigi, Laura
Lumetti, Federica
Agnusdei, Concetto Paolo
Ferrucci, Maria Grazia
Gualberti, Giuliana
Marando, Francesca https://orcid.org/0000-0001-5989-3112
Ramonda, Roberta
Cusano, Francesco
Funding for this research was provided by:
AbbVie SRL (N/A)
Article History
Received: 27 July 2020
Revised: 20 October 2020
Accepted: 26 October 2020
First Online: 6 November 2020
Compliance with ethical standards
:
: G Gualberti and F Marando are AbbVie employees and may own AbbVie stocks and options.A Delle Sedie received honoraria for invited talks, board, and meetings from Abbvie, Celgene, Lilly, Novartis; Sanofi. D Santilli declares fees for Advisory Boards or Talks from Abbvie, Abiogen, GSK, Novartis; Roche. F Cusano declares fees for Advisory Boards or Talks from Abbvie. F Prignano has been consultant, adviser, and clinical study investigator for Eli-Lilly, Abbvie, Novartis, Leo-Pharma, Abiogen-Pharma, Celgene, Janssen-Cilag, Biogen, Admirall. S Piaserico declares fees for Advisory Boards or Talks from Almirall, Lilly, Abbvie, UCB, Janssen, and Novartis. The following authors declare no conflicts of interests: R Ramonda, L Bianchi, E Baldissera, S Di Nuzzo, S. Parisi, F Lumetti, L Bigi, S Curatolo, F Caso, C Franchi, C Arcuri, RG Angileri, C De Felice, F Bandinelli, S Dastoli, G Italiano, M Romanelli, G Scotto di Luzio, A Patrì, MA Montesu, E Stroppiana, G Passiu, RD Grembiale, I De Andres, MG Ferrucci, E Lubrano, MS Chimenti, D Graceffa, P Agnusdei, SR Mercuri, M Longhi.
: Ethics committee approval from all participating centers and written informed consent for the use of personal data was obtained from every patient.